The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Open accessAbstract
Fibroblast growth factor (FGF)21 is an endocrine hormone that is expressed in multiple tissues and functions physiologically to maintain energy homeostasis. FGF21 is being pursued as a therapeutic target for diabetes and obesity because of its rapid and potent effects on improving insulin sensitivity. However, whether FGF21 enhances insulin sensitivity under physiologic conditions remains unclear. Here, we show that liver-derived FGF21 enters the circulation during fasting but also remains present and functional during the early stage of refeeding. After a prolonged fast, FGF21 acts as an insulin sensitizer to overcome the peripheral insulin resistance induced by fasting, thereby maximizing glucose uptake. Likewise, FGF21 is produced from the liver during overfeeding and mitigates peripheral insulin resistance. DIO FGF21 liver-specific knockout, but not FGF21 adipose-specific knockout, mice have increased insulin resistance and decreased brown adipose tissue–mediated glucose disposal. These data are compatible with the concept that FGF21 functions physiologically as an insulin sensitizer under conditions of acute refeeding and overfeeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In skeletal muscle, FGF21 expression, in healthy conditions, is almost undetectable, and therefore, the circulating FGF21 is predominantly produced and released by the liver.6, 12”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [12]
In the citing paper
“In skeletal muscle, FGF21 expression, in healthy conditions, is almost undetectable, and therefore, the circulating FGF21 is predominantly produced and released by the liver.6, 12”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [12]
In the citing paper
“circulating levels of FGF21 are now known to be derived primarily, if not exclusively, from the liver under physiological conditions in both rodents6 and humans7.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [6]
In the citing paper
“FGF21 treatment of isolated primary brown adipocytes, but not white adipocytes, enhances insulin-stimulated glucose uptake6.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [6]
In the citing paper
“while a lack of FGF21 exacerbates liver and metabolic dysfunction in response to high-fat diet [166]”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [166]
In the citing paper
“Notably, despite the expression of Fgf21 mRNA in these tissues, under most physiological conditions, circulating levels of FGF21 are derived primarily from the liver (46, 86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“However, when nutrients become available following a prolonged fast, FGF21 functions as a metabolic switch to facilitate the transition to the refed state by enhancing insulin-stimulated glucose uptake while acutely maintaining the actions of the fasting response (86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“These circulating levels of FGF21 are derived from the liver, as the genetic loss of Fgf21 specifically from the liver ablates plasma FGF21 levels during fasting (86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“For example, while chronic feeding of a high-fat diet clearly represents a state of cellular and mitochondrial stress for skeletal muscle, skeletal muscle does not contribute to circulating levels of FGF21 during feeding of a high-fat diet; instead, circulating levels of FGF21 are derived exclusively from the liver under these conditions (86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“Multiple studies have demonstrated that FGF21 stimulates glucose uptake in BAT in vivo (11, 27, 86, 115).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
In the citing paper
“In addition, FGF21 enhances insulin sensitivity in primary brown adipocytes (86) but not in primary white adipocytes (64, 86).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP
Rodríguez, C. I., Buchholz, F., Galloway, J. L., Sequerra, R., Kasper, J. S., Ayala, R., Stewart, A. F., & Dymecki, S. M. (2000) · Nature Genetics · doi:10.1038/75973 · Cited by 1,162
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
Kurosu, H., Choi, M., Ogawa, Y., Dickson, A. S., Goetz, R., Eliseenkova, A. V., Mohammadi, M., Rosenblatt, K. P., Kliewer, S. A., & Kuro-o, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704165200 · Cited by 748
Self-citationThe metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Kharitonenkov, A., Wroblewski, V. J., Koester, A., Chen, Y.-F., Clutinger, C. K., Tigno, X. T., Hansen, B. C., Shanafelt, A. B., & Etgen, G. J. (2007) · Endocrinology · doi:10.1210/en.2006-1168 · Cited by 738
Potthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904187106 · Cited by 704
Self-citationLin, Z., Tian, H., Lam, K. S. L., Lin, S., Hoo, R. C. L., Konishi, M., Itoh, N., Wang, Y., Bornstein, S. R., Xu, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.005 · Cited by 691
Transcriptional Control of Adipose Lipid Handling by IRF4
Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J. R., Estall, J. L., Klein, U., Maratos–Flier, E., & Rosen, E. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.005 · Cited by 597
Dutchak, P. A., Katafuchi, T., Bookout, A. L., Choi, J. H., Yu, R. T., Mangelsdorf, D. J., & Kliewer, S. A. (2012) · Cell · doi:10.1016/j.cell.2011.11.062 · Cited by 537
Self-citation
Cited by
Sorted by citations
Items 501–589 of 589
Mediators of energy homeostasis in hyperthyroidism
Patil, A., Vaikkakara, S., Dasari, M. D., Ganta, S., Sachan, A., & Vinapamula, K. S. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000511 · Cited by 2
Byun, J., & Jung, G. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150425 · Cited by 2
The role of fibroblast growth factors in cell and cancer metabolism
Price, J., & Francavilla, C. (2025) · FEBS Letters · doi:10.1002/1873-3468.70199 · Cited by 3
Fibroblast growth factor 21: new insights from human studies
Hansen, J. S., & Plomgaard, P. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000084 · Cited by 2
Bicistronic reporter mice for monitoring of Fgf21 expression
Pham, H. T. A., Lee, S., & Lee, Y. J. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.06.045 · Cited by 2
Pei, E., Wang, H., Li, Z., Xie, X., Cai, L. J., & Lin, M. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102229 · Cited by 2
Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation
Skoczeń, S., Rej, M., Kwiecińska, K., Pietrys, D., Tomasik, P., Wójcik, M., Strojny, W., Dłużniewska, A., Klimasz, K., Fijorek, K., et al. (2020) · BMC Cancer · doi:10.1186/s12885-020-06790-9 · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 2
Patel, S., Haider, A., Álvarez-Guaita, A., Bidault, G., Moustafa, J. S. E.-S., Guiu‐Jurado, E., Tadross, J. A., Warner, J., Harrison, J., Virtue, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495255 · Cited by 2
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., Koehler, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522509 · Cited by 2
Self-citationLi, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00003-2 · Cited by 2
Durrer, C. G., Islam, H., Cen, H. H., Moya-Garzón, M. D., Lyu, X., McKelvey, S., Singer, J., Batterham, A. M., Long, J. Z., Johnson, J. D., et al. (2024) · Nutrition & Metabolism · doi:10.1186/s12986-024-00807-x · Cited by 2
Lin, X., Davidsohn, N., Boyce, S., McIntyre, M., Zhang, M., Gencarelli, M., Ascheim, D. D., Delmar, M., & Cerrone, M. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.030 · Cited by 1
Merrild, C., Johansen, V. B. I., Clemmensen, C., & Ranea‐Robles, P. (2026) · The Journal of Physiology · doi:10.1113/jp289817 · Cited by 1
Lipid homeostasis plays a critical role in inherited and acquired retinal diseases
Bhattacharyya, A., & Choudhary, V. (2026) · Communications Biology · doi:10.1038/s42003-026-10025-1 · Cited by 2
Huang, L., Liu, P., Chen, Q., Hu, K., Li, S., Lee, A., Wabitsch, M., Zhu, L. J., Yu, Q., Davis, R. J., et al. (2026) · Science Advances · doi:10.1126/sciadv.aed2780 · Cited by 1
Holleboom, A. G., & Schattenberg, J. M. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101957 · Cited by 1
Brown fat protects against hepatic oxidative stress by remodeling the circulating metabolome
Wang, D., Li, M., Lu, T., Matsushita, M., Sakai, J., Saito, M., Yoneshiro, T., & Kajimura, S. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.06.020 · Cited by 1
Malaikah, S., Willis, S. A., Henson, J. J., Sargeant, J. A., Yates, T. E., Thackray, A. E., Goltz, F. R., Roberts, M. J., Bernard-Deshong, D., Aithal, G. P., et al. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2022-0445 · Cited by 1
Luo, X., Tan, C. N., Fang, T., Xu, C.-Y., Zheng, Z., Pang, Q., He, X.-A., Cao, J., & Duan, J. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i7.1304 · Cited by 1
Cold environments and human metabolism: A traditional chinese medicine perspective
Zhao, T., Ma, Y., Zhang, J., Zhou, X., Zhou, Y., & Yan, J. (2024) · Frigid Zone Medicine · doi:10.1515/fzm-2024-0009 · Cited by 1
Lu, S.-L., Pan, Z., Cui, Z. G., Wang, J., Yang, J., Lv, Y., Cao, C., & Huang, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123344 · Cited by 1
Pancreatic Islets as a Target of Adipokines
Reiterer, M., Gilani, A., & Lo, J. C. (2022) · Comprehensive physiology · doi:10.1002/j.2040-4603.2022.tb00238.x · Cited by 1
FGF21 Conducts a Metabolic Orchestra and Fat Is a Key Player
Whittle, A. J. (2016) · Endocrinology · doi:10.1210/en.2016-1193 · Cited by 1
Li, S., Zhou, X., Jo, E., Mahzari, A., Fouda, S., Li, D., Zhang, K., & Ye, J. (2018) · Bioscience Reports · doi:10.1042/bsr20181873 · Cited by 1
The Metabolic Effects of FGF21: From Physiology to Pharmacology
Song, P. (2020) · JoLS Journal of Life Sciences · doi:10.5352/jls.2020.30.7.640 · Cited by 1
Metabolic Responses to Energy-Depleted Conditions
SUZUKI, T., Komatsu, T., Shibata, H., & Inagaki, T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100391 · Cited by 2
Yasen, M., Jiang, L., Sharofova, M. U., Xin, X., Nuraliev, Y., Ye, J., & Aisa, H. A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.28.316349 · Cited by 1
Cheng, T. W., & Leung, P. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101992 · Cited by 1
A liver-specific mitochondrial carrier that controls gluconeogenesis and energy expenditurePreprint
Yook, J.-S., Taxin, Z. H., Yuan, B., Oikawa, S., Auger, C., Mutlu, B., Puigserver, P., Hui, S. T., & Kajimura, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519308 · Cited by 1
Liu, C., Schönke, M., Spoorenberg, B., Lambooij, J. M., van der Zande, H. J. P., Zhou, E., Tushuizen, M. E., Andréasson, A., Park, A., Oldham, S. N., et al. (2023) · eLife · doi:10.7554/elife.83075.sa2 · Cited by 1
FGF21 Counteracts Adipose Tissue Wasting in Cancer-Associated CachexiaPreprint
Österreicher, T., Kührer, K., Höbler, A.-L., Berghoff, A. S., Gottmann, L., Udonta, F., Körbelin, J., Pollak, D. D., Hengstschläger, M., Loges, S., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4896832 · Cited by 1
Stéatose et résistance à l’insuline : implication des hépatokines
Bertrand, C., Valet, P., & Castan‐Laurell, I. (2015) · Obésité · doi:10.1007/s11690-015-0492-7
Potensi Terapeutik Fibroblast Growth Factor 21 terhadap Resistensi Insulin
Kurniasari, K., & Arozal, W. (2015) · eJournal Kedokteran Indonesia · doi:10.23886/ejki.3.5049
Receptor Tyrosine Kinases and the Insulin Signaling System
White, M. F. (2017) · Endocrinology · doi:10.1007/978-3-319-27318-1_7-1
Higgins, C. B., Zhang, Y., Mayer, A. L., Fujiwara, H., Stothard, A. I., Graham, M. J., Swarts, B. M., & DeBosch, B. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/267781
The Role Of Crebh In Hepatic Energy Regulation Under Metabolic Stress
Mendez, R. (2015) · Human Biology
Role of GPRC6A in Regulating Hepatic Energy MetabolismPreprint
Pi, M., Xu, F., Ye, R.-S., Nishimoto, S. K., Kesterson, R. A., Williams, R. W., Lu, L., & Quarles, L. D. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3396491
Tissue Specific Roles of Fatty Acid Oxidation
Lee, J. (2016)
Brown Adipose Tissue in Obesity and Diabetes
Alcalá, M., Herrero, L., Serra, D., & Viana, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_4
Bayoumi, A. (2020) · The Sydney eScholarship Repository (The University of Sydney)
Yunker, A. G., Alves, J. M., LUO, S. H., ANGELO, B. C., DEFENDIS, A. W., Pickering, T. A., Jann, K., Monterosso, J. R., & Page, K. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.29.446318
Ladbury, J. E. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737907472.793574673
Cheng, T. W., & Leung, P. S. (2017) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101992-1
Castro, É. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2021.tde-14012022-182538
Obo, T., Hashiguchi, H., Matsuda, E., Kawade, S., Ogiso, K., Iwai, H., Ataka, K., Yasuda, O., Arimura, A., Deguchi, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.19.563064
Cross-talk between hepatokines as Liver indused-exercise factors and organokinesPreprint
Rad, R. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3734627/v1
Obo, T., Hashiguchi, H., Matsuda, E., Kawade, S., Ogiso, K., Iwai, H., Ataka, K., Yasuda, O., Arimura, A., Deguchi, T., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3919360/v1
Бажан, Н. М., & En, M. (2023) · Успехи физиологических наук · doi:10.31857/s0301179823040033
Endocrine fibroblast growth factors in domestic animals
Brinker, E. J., Hardcastle, M., Dittmer, K. E., & Graff, E. C. (2024) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2024.106872
ASK1 overexpression protects from HFD-induced body weight gain via FGF21Preprint
Goergen, A., Challa, T. D., Borsigova, M., Villarroel-Vicente, C., van Krieken, P. P., Wueest, S., & Konrad, D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.23.634369
NASH Cirrhosis: A Systematic Review of Phase 2B Trials
Singh, B., Ramanan, S. P., Singh, W., Kaur, G., Grover, P., & Sridhar, N. (2025) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2025.154014
Sex-specific metabolic responses to modulation of the glucagon-FGF21 axis in female micePreprint
Merrild, C., Johansen, V. B. I., Clemmensen, C., & Ranea‐Robles, P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.09.647697
Xie, X., Kong, L., Lan, Z., Liu, X., Li, X., Cai, J., Meng, L., Yuan, G., Huang, C., Chen, Y., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5265213
Intermittent Fasting in Female Reproduction: A Double-Edged Sword
Yang, X., Liu, W., Zhuo, Y., Luo, T. F., Wu, D., & Hua, L. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf107 · Cited by 1
Schmidt, H. M., Tarling, E. J., & Vallim, T. Q. D. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2512733122
Bruse, J., Marbach, C., Polizzi, A., Landré, T., Salvi, J., Alquier‐Bacquie, V., Shiou-Ping, C., Huillet, M., Rives, C., Martin, C. M. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.22.683899
Dallaire‐Théroux, C., Denis, H. L., Cottez, R. J., Tremblay, C., Provencher, A., Valentin‐Escalera, J., Leclerc, M., Loiselle, A., Tournissac, M., Potvin, O., et al. (2025) · medRxiv · doi:10.1101/2025.11.26.25340689
Skoczeń, S., Rej, M., Kwiecińska, K., Pietrys, D., Tomasik, P. J., Wójcik, M., Strojny, W., Dłużniewska, A., Klimasz, K., Fijorek, K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12134229
Skoczeń, S., Rej, M., Kwiecińska, K., Pietrys, D., Tomasik, P. J., Wójcik, M., Strojny, W., Dłużniewska, A., Klimasz, K., Fijorek, K., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12134223
Durrer, C. G., Islam, H., Cen, H. H., Moya-Garzón, M. D., Lyu, X., McKelvey, S., Singer, J., Batterham, A. M., Long, J. Z., Johnson, J. D., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26725835
Guo, S., Xi, Y., Qi, J., Yang, Z., Han, X., Ling, W., Bai, L., Huang, A., Hu, S., Hu, J., et al. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106525
Prolonged Fasting: Scoping Review with ☸SAIMSARA
SAIMSARA (2026) · SAIMSARA Journal · doi:10.62487/saimsara93074bf6
Zhang, Y., Li, Y., Wang, Q., Pang, J., Wang, D., Yuan, T., & Liu, Z. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71287
Zhang, Y., Liu, D., Lu, Y., Kang, P., Liu, X., Wang, Q., Chen, A., Cheng, D., Wu, L., Li, Q., et al. (2026) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0814
Hypothalamus-liver talks: whispers in the language of metabolism
Ferreira, V., Fernández-González, I., Vattathara, J. J., Rodríguez-Díaz, A., Fernández-Sanmartín, P., & Diéguez, C. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10031-y
Interactions between circadian clocks and feeding behaviour
Sen, S. (2018) · theses.fr (ABES) · doi:10.70675/a9aacc00z1b8ez46fbz9494z07029578de62
Juber, M. C., King-McAlpin, S., Buscaglia, P., Sebag, J. A., & Potthoff, M. J. (2026) · Endocrinology · doi:10.1210/endocr/bqag040
Self-citationBarretto, S. A. (2019) · theses.fr (ABES) · doi:10.70675/fa5edab1z50c0z4b21z96d3z01d01036532a
Coopération oncogénique et effets métaboliques de FGF19 dans le carcinome hépatocellulaire
Bedoya, J. U. (2021) · theses.fr (ABES) · doi:10.70675/d2df913bz04e7z457dzb21dzf6ae23303e0c
Infections virales respiratoires et tissus adipeux blancs : Exemple de la grippe et de la COVID-19
Barthelemy, J. (2022) · theses.fr (ABES) · doi:10.70675/6439a82ez7179z48e3zbb8ez93846ae0ac14
Bruse, J., Marbach, C., Polizzi, A., Landré, T., Salvi, J., Alquier‐Bacquie, V., Chen, S.-P., Huillet, M., Rives, C., Céline, M., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00790-9
Liver-nervous system axis: pathways, dysregulation, and translational perspectives
Hao, D., Hu, Y., Luo, W., Li, S., Yan, Y., & Zhou, J. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03875-3
Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges
Dordoe, C., Kai-ming, G., Bwalya, C., Huang, W., Chen, S., Chen, J., Wang, X., Wang, P., Li, X., & Li, L. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01832-7 · Cited by 1
Peptide hormone-based combinational pharmacotherapies for chronic metabolic diseases
Chui, Z. S. W., Xue, Y., Wu, X., & Xu, A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100150
ASK1 ‐Induced FGF21 Synthesis in the Liver Prevents Obesity in Mice
Goergen, A., Challa, T. D., Villaroel‐Vicente, C., Borsigova, M., van Krieken, P. P., Wolfrum, C., Blüher, M., Wueest, S., & Konrad, D. (2026) · Obesity · doi:10.1002/oby.70261
Positive actions of fibroblast growth factor 21 on female zebrafish reproductive axis
Uju, C. N., & Unniappan, S. (2026) · Theriogenology · doi:10.1016/j.theriogenology.2026.118106
Calo, J., Ferreiro, D., Pérez-Tierra, G., Soengas, J. L., & Velasco, C. (2026) · Comparative biochemistry and physiology. Part A, Molecular & integrative physiology · doi:10.1016/j.cbpa.2026.112057
Adipokine in Metabolic Liver Disease: Adipo–Brain–Liver Cross talk
苏喻乐, Yang, Y., Sun, W., Yu, Z., Wang, Y., 刘世新, Chen, Z., Li, Y., Yang, X., Liu, J., et al. (2026) · International Journal of Endocrinology · doi:10.1155/ije/9009628
Advances in FGF/FGFR Signaling: Implications for Disease and Therapy
Song, M., Liu, X., Xiao, Y., Li, Y., & Zhao, H. (2026) · MedComm · doi:10.1002/mco2.70922
Sewell, P. E., & Jensen, C. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1908078
Ju, W., Zhang, C., Zhang, T., Liu, Y., Wang, X., Zeng, L., Cao, Y., Lin, H., Li, O., Wang, P. G., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00615-0
Liver-derived FGF21 contributes to protection against Alzheimer’s disease pathogenesis
Al‐Lahham, R., Dweik, Q., Murthy, S. G. S. S., Gill, S. K., Krishnan, B., Valdebenito, S., Eugenín, E. A., & Elferink, C. J. (2026) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2026-0020
Biological functions and emerging interplay of FGF21 and GDF15 in metabolic diseases and aging
Salmón‐Gómez, L., Keipert, S., Catalán, V., Rodrı́guez, A., Becerril, S., Frühbeck, G., & Gómez‐Ambrosi, J. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00627-w
Metadata
- Authors
- Markan, K. R., Naber, M. C., Ameka, M. K., Anderegg, M. D., Mangelsdorf, D. J., Kliewer, S. A., Mohammadi, M., & Potthoff, M. J.
- Affiliations
- University of Iowa (US)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- New York University (US)
- Corresponding author
- Potthoff, Matthew J.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2014-11-13
- Volume
- 63
- Issue
- 12
- Pages
- 4057-4063
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC4238010
- OpenAlex
- W2133706171
- Cited by
- 590
- References
- 23
- Citations by year
- 2026: 26 · 2025: 42 · 2024: 41 · 2023: 60 · 2022: 56 · 2021: 64 · 2020: 62 · 2019: 60 · 2018: 44 · 2017: 53 · 2016: 51 · 2015: 28 · 2014: 3
- FWCI
- 18.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5p60dk020593-31)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK020593, DK 20593, R01DK067158, P30DK020593)
- National Institute of Dental and Craniofacial Research (R01DE013686)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- FGF21, insulin sensitivity, insulin resistance, refeeding, overfeeding, fasting, glucose uptake, brown adipose tissue, energy homeostasis, obesity, liver-specific knockout
- MeSH terms
- Adipose Tissue, Animals, Blood Glucose, Adipose Tissue, Brown, Fasting, Fibroblast Growth Factors, Glucose, Insulin, Insulin Resistance, Liver, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
